Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
Philip T. Ninan, MD: Social Anxiety Disorder and the Neurobiology of Social Relationships
1
x
$
30.00
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
1
x
$
30.00
View Cart
Checkout
Home
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
“Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj” has been added to your cart.
View cart
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 3 Articles
Tags:
antidepressant
,
deprenyl
,
depression
,
donald-s-robinson
,
medworks-media
,
monoamine-oxidase-inhibitors
,
phenelzine
,
psychopharmacology-bulletin
,
selegiline
,
transdermal
,
tranylcypromine
,
tyramine-sensitivity
Description
Description
Donald S. Robinson, MD
GENERAL PSYCHOPHARMACOLOGY
Monoamine Oxidase Inhibitors: A New Generation
Donald S. Robinson, MD
Related products
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Page load link
Go to Top
